TL;DR
Refocus Group's VisAbility implants are tiny inserts placed in the white of the eye to give the eye's focusing muscle more room to work, with the goal of bringing back close-up reading vision without glasses. In a report from one site of an earlier U.S. trial, all 20 treated eyes read at 20/40 or better without glasses a year later. The details, the numbers and our odds on what comes next are below the line. Subscribe to read them.
Below the line, for paid subscribers: what the new trial measures, the earlier results, what happened at the FDA in 2020, our Odds board on 2 milestones, our labeled speculation, and every source.



